Five lives have been claimed and 720 adverse drug reactions have occurred in Britain since the launch of Franceâs Sanofi-Aventis SAâs weight-loss drug, Acomplia, two years ago; this, according to a posting on the United Kingdomâs drug regulatorâs Website this week. Acompliaâ"known generically as rimonabantâ"had been slated to be a multi-billion dollar seller; however, following [...]
No comments:
Post a Comment